These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 8402464)
1. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder. Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464 [TBL] [Abstract][Full Text] [Related]
2. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility. Sørensen FB; Sasaki M; Fukuzawa S; Yamabe H; Olsen S; Yoshida O Lab Invest; 1994 Feb; 70(2):242-54. PubMed ID: 8139265 [TBL] [Abstract][Full Text] [Related]
3. DNA level and stereologic estimates of nuclear volume in squamous cell carcinomas of the uterine cervix. A comparative study with analysis of prognostic impact. Sørensen FB; Bichel P; Jakobsen A Cancer; 1992 Jan; 69(1):187-99. PubMed ID: 1727663 [TBL] [Abstract][Full Text] [Related]
4. Quantitative histopathology in ductal carcinoma of the breast. Prognostic value of mean nuclear size and mitotic counts. Ladekarl M Cancer; 1995 Apr; 75(8):2114-22. PubMed ID: 7697602 [TBL] [Abstract][Full Text] [Related]
5. Prognostic, quantitative histopathologic variables in lobular carcinoma of the breast. Ladekarl M; Sørensen FB Cancer; 1993 Nov; 72(9):2602-11. PubMed ID: 8402482 [TBL] [Abstract][Full Text] [Related]
6. Stereological estimation of nuclear volume and other quantitative histopathological parameters in the prognostic evaluation of supraglottic laryngeal squamous cell carcinoma. Sørensen FB; Bennedbaek O; Pilgaard J; Spaun E APMIS; 1989 Nov; 97(11):987-95. PubMed ID: 2686723 [TBL] [Abstract][Full Text] [Related]
7. Quantitative histopathological variables in in situ and invasive ductal and lobular carcinomas of the breast. Ladekarl M; Sørensen FB APMIS; 1993 Dec; 101(12):895-903. PubMed ID: 8110444 [TBL] [Abstract][Full Text] [Related]
8. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335 [TBL] [Abstract][Full Text] [Related]
9. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases. Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583 [TBL] [Abstract][Full Text] [Related]
10. Independent clinical, histological and quantitative prognostic factors in transitional-cell bladder tumours, with special reference to mitotic frequency. Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H Int J Cancer; 1992 May; 51(3):396-403. PubMed ID: 1592531 [TBL] [Abstract][Full Text] [Related]
11. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors. Ladekarl M APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191 [TBL] [Abstract][Full Text] [Related]
12. Stereological estimates of nuclear volume in the prognostic evaluation of primary flat carcinoma in situ of the urinary bladder. Sørensen FB; Jacobsen F Histopathology; 1991 Jun; 18(6):531-9. PubMed ID: 1879813 [TBL] [Abstract][Full Text] [Related]
13. Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period. Sørensen FB Cancer; 1989 May; 63(9):1784-98. PubMed ID: 2702586 [TBL] [Abstract][Full Text] [Related]
14. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659 [TBL] [Abstract][Full Text] [Related]
15. MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder: clinical significance and comparison with other prognostic factors. Oosterhuis JW; Schapers RF; Janssen-Heijnen ML; Smeets AW; Pauwels RP Cancer; 2000 Jun; 88(11):2598-605. PubMed ID: 10861439 [TBL] [Abstract][Full Text] [Related]
16. Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient follow-up for 15 years or longer. Fujikawa K; Matsui Y; Kobayashi T; Miura K; Oka H; Fukuzawa S; Sasaki M; Takeuchi H; Okabe T Int J Urol; 2003 Mar; 10(3):149-52. PubMed ID: 12622711 [TBL] [Abstract][Full Text] [Related]
17. Grading of superficial bladder cancer by quantitative mitotic frequency analysis. Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R; Haapasalo H J Urol; 1993 Jan; 149(1):36-41. PubMed ID: 8417213 [TBL] [Abstract][Full Text] [Related]
18. Stereologic estimates of nuclear volume in noninvasive bladder tumors (Ta) correlated with the recurrence pattern. Nielsen K; Orntoft T; Wolf H Cancer; 1989 Dec; 64(11):2269-74. PubMed ID: 2804918 [TBL] [Abstract][Full Text] [Related]
19. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder. al-Abadi H; Nagel R J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829 [TBL] [Abstract][Full Text] [Related]
20. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho R Eur J Cancer; 1992; 29A(1):69-75. PubMed ID: 1445749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]